GERMANI, MASSIMILIANO ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 513
EU - Europa 419
AS - Asia 252
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
Totale 1.192
Nazione #
US - Stati Uniti d'America 505
CN - Cina 247
IE - Irlanda 156
UA - Ucraina 85
DE - Germania 48
FI - Finlandia 44
SE - Svezia 30
BE - Belgio 20
GB - Regno Unito 14
IT - Italia 11
CA - Canada 8
FR - Francia 8
BR - Brasile 4
EU - Europa 4
GR - Grecia 2
IL - Israele 2
KR - Corea 2
KZ - Kazakistan 1
NL - Olanda 1
Totale 1.192
Città #
Dublin 154
Chandler 133
Jacksonville 99
Nanjing 64
Beijing 43
Ann Arbor 31
New York 30
Nanchang 27
Ashburn 21
Brussels 20
Hebei 20
Shenyang 20
Tianjin 19
Princeton 18
Lawrence 17
Boardman 14
Medford 14
Wilmington 14
Jiaxing 13
Dearborn 11
Helsinki 10
Changsha 9
Hangzhou 9
Woodbridge 9
Shanghai 6
Toronto 5
Kunming 4
Milan 4
Norwalk 4
Houston 3
Seattle 3
Verona 3
Zhengzhou 3
Fairfield 2
Netanya 2
Ningbo 2
Washington 2
Winnipeg 2
Amsterdam 1
Changchun 1
Des Moines 1
Fuzhou 1
Grugliasco 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Henderson 1
Lanzhou 1
Lodi Vecchio 1
Los Angeles 1
Pavia 1
Taizhou 1
Walnut 1
Totale 879
Nome #
A non parametric population approach for selecting biomarkers of a drug action 98
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 90
A Bayesian approach to non-parametric AUC estimation in population studies 78
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 78
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 77
Modeling myelosuppression in patients treated with anticancer drugs 75
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 73
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 70
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 67
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 67
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 66
A tumor growth inhibition model in drugs combination regimens 66
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 65
Statistical methods to detect immune responses to drug administration 64
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts 59
Re: Antitumor Efficacy Testing in Rodents 56
A model based approach to the in vitro evaluation of anticancer activity 51
Totale 1.200
Categoria #
all - tutte 2.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201934 0 0 0 0 0 0 0 3 21 2 0 8
2019/2020307 68 113 0 19 1 19 7 22 7 29 22 0
2020/2021156 21 16 4 20 0 20 2 20 4 22 23 4
2021/202283 4 2 5 1 2 0 1 6 3 5 14 40
2022/2023385 34 40 3 25 41 33 2 23 165 4 11 4
2023/2024103 8 9 9 13 8 47 0 9 0 0 0 0
Totale 1.200